Medicinal product name Pramipexole Orion 1.1 mg tablets
Pharmaceutical form Tablet
Strength 1.1 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Package leaflet MS Word document 18-06-2020
Summary of product characteristics MS Word document 18-06-2020
ATC code N04BC05 Anti-parkinson drugs

Important notice

Additional information regarding the use for persons aged 75+

If used as "ANTI-PARKINSON DRUGS"
SubstanceClassComment
PramipexolumCSuitable for older persons, with specific cautions. Sedative. Start therapy under specialist supervision. Reduce the dose in even moderate renal insufficiency. The most common adverse effects are orthostatic hypotension, gastrointestinal symptoms, drowsiness, hallucinations, confusion and sudden bouts of falling asleep. Take interactions into account, especially with antipsychotics.

Medicinal products (2)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N30: 3 × 10
(1,1 mg)
OPA/Al/PVC/Al blister    10-0056-01 Labelling text Labelling text Feb 21, 2019
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N100: 10 × 10
(1,1 mg)
OPA/Al/PVC/Al blister    10-0056-02 Labelling text Labelling text Feb 21, 2019

Registration information

Marketing authorisation No. 10-0056
Date of authorisation Jan 25, 2010
MA valid until For unlimited time
Marketing authorisation holder, country Orion Corporation, Finland